Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations (Unaudited)

v3.24.3
Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Licensing revenues $ 675
Operating expenses:        
Research and development 3,045 3,372 14,726 8,669
General and administrative 3,206 2,566 8,130 6,467
Total operating expenses 6,251 5,938 22,856 15,136
Loss from operations (6,251) (5,938) (22,856) (14,461)
Other income (expenses):        
Interest income 416 227 947 475
Interest expense (15) (18) (51) (63)
Change in fair value of warrant liability 1,754 1,396 6,756 (8,697)
Total other income (expenses) 2,155 1,605 7,652 (8,285)
Net loss (4,096) (4,333) (15,204) (22,746)
Net loss attributable to common stockholders $ (4,096) $ (4,405) $ (16,299) $ (23,613)
Net loss per share attributable to common stockholders, basic (in Dollars per share) $ (0.05) $ (0.13) $ (0.3) $ (1.12)
Net income (loss) per share attributable to common stockholders, diluted (in Dollars per share) $ (0.05) $ (0.13) $ (0.3) $ (1.12)
Weighted-average shares outstanding used in computing net loss per share, basic (in Shares) 88,943,212 32,633,074 54,073,701 21,100,206
Weighted-average shares outstanding used in computing net income (loss) per share, diluted (in Shares) 88,943,212 32,633,074 54,073,701 21,100,206
Series A-1 Preferred Stockholders        
Other income (expenses):        
Deemed dividends to Series A-1 preferred stockholders $ (72) $ (867)
Series B Holders        
Other income (expenses):        
Cash dividends to Series B-1 preferred stockholders $ (1,095)